More Education

Blog Embracing Biosimilars

By Christina Ha, MD

I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.

Read More

Related Content

Paper What Patients Should Know About Biologics

Event Report AfPA’s 2024 National Policy & Advocacy Summit Report

Paper Nurturing the Potential of the Biosimilar Market

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below:

(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';}(jQuery));var $mcj = jQuery.noConflict(true);